Bruk av naltrekson i lave doser utenfor godkjent bruksområde

dc.contributor.author	Ringerike, Tove
dc.contributor.author	Pike, Eva
dc.contributor.author	Nevjar, Janicke
dc.contributor.author	Klemp, Marianne
dc.date.accessioned	2018-01-21T16:41:03Z
dc.date.available	2018-01-21T16:41:03Z
dc.date.created	2015-11-20T22:42:23Z
dc.date.issued	2015
dc.identifier.isbn	978-82-8121-952-6
dc.identifier.uri	http://hdl.handle.net/11250/2478562
dc.language.iso	nob
dc.publisher	Nasjonalt kunnskapssenter for helsetjenesten
dc.relation.ispartof	Rapport fra Kunnskapssenteret
dc.relation.ispartofseries	Rapport fra Kunnskapssenteret
dc.subject.mesh	Naltrexone
dc.subject.mesh	Fibromyalgia
dc.subject.mesh	Alcoholism
dc.subject.mesh	Multiple Sclerosis
dc.subject.mesh	Fatigue Syndrome, Chronic
dc.subject.mesh	Amyotrophic Lateral Sclerosis
dc.subject.mesh	Crohn Disease
dc.subject.mesh	Opioid-Related Disorders
dc.subject.mesh	Inflammatory Bowel Diseases
dc.subject.mesh	Neoplasms
dc.subject.mesh	Pain
dc.subject.mesh	HIV Infections
dc.subject.mesh	Pharmaceutical Preparations
dc.subject.mesh	Drug Utilization
dc.subject.mesh	Systematic Review
dc.title	Bruk av naltrekson i lave doser utenfor godkjent bruksområde
dc.title.alternative	The use of naltrexone in low doses beyond the approved indication
dc.type	Research report
dc.description.version	publishedVersion
dc.source.pagenumber	89
dc.source.issue	8
dc.identifier.cristin	1291619
cristin.unitcode	7502,0,0,0
cristin.unitcode	7502,7,2,5
cristin.unitname	Folkehelseinstituttet
cristin.unitname	Legemidler og helseøkonomi
cristin.ispublished	true
cristin.fulltext	original